跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IMMUNE GLOBULIN INTRAVENOUS (HUMAN), 5% - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
IMMUNE GLOBULIN INTRAVENOUS (HUMAN), 5%
Authorized
STANDARD
IMMUNE GLOBULIN INTRAVENOUS (HUMAN), 5%
TALECRIS BIOTHERAPEUTICS INC
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
8cccc5b48a4a7ef2
Company
TALECRIS BIOTHERAPEUTICS INC
Type
Standard
Approval Details
Approval Id
8cccc5b48a4a7ef2
Drug Approval Canada Name
IMMUNE GLOBULIN INTRAVENOUS (HUMAN), 5%
Product Name
IMMUNE GLOBULIN INTRAVENOUS (HUMAN), 5%
Status
Cancelled Post Market
Status Date
2006-08-03
Original Market Date
1997-11-03
Din
02230919
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Schedule D
Ahfs
80:04.00
Atc Original
J06BA02 IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASC. ADM.
Atc Name
j 06 ba 02
Aig Number
0106267014
Company Name
TALECRIS BIOTHERAPEUTICS INC
Company Address
8368 Us 70 Business Hwy. West, Clayton, North Carolina, United States, 27520-9464
Company Detail Path
/organization/talecris-biotherapeutics-inc-raleigh-north-carolina-united-states
Company Information
Pharmaceutical Company Name
TALECRIS BIOTHERAPEUTICS INC
Country Name
United States
Province Name
North Carolina
City Name
raleigh,north carolina,country_us
Address
7324 Mill Ridge Rd
Active Ingredients
IMMUNOGLOBULIN (HUMAN)
5 G / 100 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
8cccc5b48a4a7ef2
Type
Standard
Back to Health Canada Approvals